Russian Heart Failure Journal 2008year Comorbidity in chronic obstructive lung disease


To access this material please log in or register

Register Authorize
2008/

Comorbidity in chronic obstructive lung disease

Karoly N. A., Orlova E. E., Markova A. V., Rebrov A. P.

Keywords:

DOI:

Urgency. Significance of comorbidity as a predictive marker of general mortality in patients with obstructive lung disease (COLD) has been increasing in recent years. Aim. To study comorbidity and its contribution to mortality of patients with COLD. Material and methods. Retrospective analysis was performed on case histories of 125 patients with COLD and 54 sex- and age-matched patients with osteoarthrosis. Results. Mean comorbidity index was twofold higher in patients with COLD than in patients with osteoarthrosis (p<0.001). Comorbidity index increased as the course of COLD became more severe (p<0.01). Dynamic observation of 77 patients with COLD for 3–5 years allowed isolating a group of patients with predicted adverse outcomes. Patients who died had comorbidity index scores >3 significantly more frequently (p<0.001). A significant correlation was found between the comorbidity index and the time that had elapsed between the moment of index determination and death of the patient (r=-0.54; p<0.05). Therefore the comorbidity index can be used in practice as a measure of  risk for death in patients with COLD. An increase in comorbidity index score to >3 places a patient to the group of high risk, which should be taken into account by a physician in managing the patient.
    1.    Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: role of comorbidities. Eur Respir J. 2006;28 (6):1245–1257.
    2.    Lopez AD, Shibuya K, Rao C et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J. 2006;27 (2):397–412.
    3.    Pauwels RA, Buist AS, Calverley PM et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI / WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001;163 (5):1256–1276.
    4.    Siafakas NM, Vermeire P, Pride NB et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J. 1995;8 (8):1398–1420.
    5.    Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. Ann Intern Med. 1980;93 (3):391–398.
    6.    Gerardi DA, Lovett L, Benoit-Connors ML et al. Variables related to increased mortality following out patient pulmonary rehabilitation. Eur Respir J. 1996;9 (3):431–435.
    7.    Schols AM, Slangen J, Volovics L, Wouters EF. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157 (6 Pt 1):1791–1797.
    8.    Landbo C, Prescott E, Lange P et al. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160 (6):1856–1861.
    9.    Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS / ERS position paper. Eur Respir J. 2004;23 (6):932–946.
    10.    Диагностика и коррекция нарушений липидного обмена с целью профилактики и лече­ния атеро­склероза (Разработаны Комитетом экспертов Всероссийского научного общества кардиологов) http: www.cardiosite.ru / medical / recom – lipid. asp.
    11.    Conroy RM, Pyorala K, Fitzgerald AP et al. Estimation of ten-year risk of fatal cardiovascular disease in EUROPE; the SCORE project. Eur Heart J. 2003;24 (11):987‑1003.
    12.    Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40 (5):373–383.
    13.    Hall WH, Ramachandran R, Narayan S et al. An electronic application for rapidly calculating Charlson comorbidity score. BMC Cancer. 2004;4:94.
    14.    Celli BR, Cote CG, Marin JM et al. The body-mass index, airflow obstruction, dyspnea, and Exercise Capacity Index in Chronic Obsructive Pulmonary Disease. N Engl J Med. 2004;350 (10):1005–1012.
    15.    Almagro P, Calbo E, Ochoa de Echagüen A et al. Mortality after hospitalization for COPD. Chest. 2002;121 (5):1441–1448.

To access this material please log in or register

Register Authorize
Ru En